Final-Program-ATS-2023-AP.vp

TUESDAY • MAY 23

267

P303 A Novel Dry Powder, ABN101 Broad-spectrum, Anti-viral Inhaler to Avoid and Treat Global Respiratory Virus Pandemics/ H.S. Choi, Seoul, Korea, Republic of P304 12-Month Follow-up Study of Patients After Hospitalization for COVID-19/ I.O. Rosas, Houston, TX P305 Engineered Derivative of Soluble ACE2 for Enhanced Catalytic Activity and Pharmacokinetics Shows Profoundly Improved Therapeutic Efficacy for SARS-CoV-2-induced Lung Injury and Mortality/ L. Zhang, Pittsburgh, PA P306 The Impact of the Microbiome on Pathophysiology Following Early-life Respiratory Syncytial Virus Infection/ K. Yagi, Ann Arbor, MI P307 Differences in the Longitudinal Blood Proteomic Profiles of Vaccinated and Unvaccinated SARS-CoV-2 Patients/ J.A. Huapaya, Bethesda, MD P308 Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III/ F.R. Valerio Pascua, San Pedro Sula, Honduras P309 Comparison of Patient-Reported Post-acute Sequelae SARS-CoV-2 (PASC) Respiratory Symptoms With Pulmonary Function Tests (PFTS) in a Post-COVID Patient Population/ J. Cirillo, New York, NY P310 Patient Characteristics and Clinical Outcomes of Adults Hospitalized With Viral Lung Infection: A US Claims Database Study/ B. Emmanuel, Gaithersburg, MD P311 Pulmonary Embolism (PE) in COVID-19 Patients at Five Scripps Health Hospitals, 2020-2021: Analysis of Clinical Characteristics andOutcome Indicators/ C. Suh, La Jolla, CA P312 Bacterial Coinfections in COVID-19 Patients With Acute Respiratory Failure: Japan National Registry Survey/ K. Yamamoto, Okinawa, Japan P313 Cannabis Smoke Exposure Hinders Viral Clearance and Suppresses Immune Responses to Influenza A Infection in Mice/ N. Milad, Hamilton, Canada P314 Severity of Dyspnea During Hospitalization and Post-hospitalization Among Mild and Moderate COVID-19 Patients at Persahabatan Hospital Jakarta, Indonesia/ A.R. Dinni, Jakarta, Indonesia

P287 An Uncommon Case of Shock in a Patient With COVID-19 Pneumonia/ V. Somnay, Louisville, KY P288 Spontaneous Pneumothorax Following COVID19 Infection With Recurrent Respiratory Failure/ D. Bhattarai, Danbury, CT P289 Prognostic Value of Albumin Globulin Ratio in COVID-19 Patients in a Community Hospital in Newark: A Retrospective Analysis/ K.K. Trivedi, Newark, NJ P290 Temporal Dynamics in SARS-CoV-2 Viral Shedding: A Report of 3 Cases Diagnosed With COVID-19 Pneumonia by BAL With Serial Negative NPS/ F. Poli, Miami, FL P291 Predictors of Mortality of Hospitalized Patients With COVID 19 Pneumonia/ M.K. Ahmed, Assiut, Egypt P292 COVID-19 Pneumonia Complicated by Pulmonary Embolism and Delayed Empyema/ C. Tseng, Danbury, CT P293 Neutralizing Antibody Response Against SARS CoV2 Among Adult Individuals Immunized With a COVID-19 Vaccine/ R.S. Pagcatipunan, Quezon City, Philippines P294 A Systematic Review and Meta-analysis of Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Mega Dose Vitamin D/ M. Nguyen, Las Vegas, NV P295 Complete Resolution of Lung Cavitary Mass Following COVID-19 Infection/ E.L. Amaechi, Bronx, NY P296 Possible and Confirmed COVID-19 Patients Data at Our Hospital/ T. Ozlu, Trabzon, Turkey P297 Pathogen-Agnostic Transcriptional Responses Are Preserved in Mouse and Human Lung Epithelium During Inducible Resistance Signaling Against Respiratory Infections/ J. Pantaleón García, Houston, TX P298 Toll-like Receptor-9 Activation Promotes Persistent Inflammation in the Lung During Influenza Infection/ H. Essayas, New Haven, CT P299 Efficacy of Bacterial Lysate OM-85 in Murine Rhinovirus1b-Infection Models/ H. Obernolte, Hannover, Germany P300 Secondary Acrocyanosis, the Only Visible Sign Present in a “Long COVID” Patient/ S.M. Rosa Santiago, San Juan, Puerto Rico P301 COVID-19 and Empyema: Review of an Uncommon Complication From a Case Report/ A.J. Duval, Newark, NJ P302 Metabolite Profiling of Unsaturated Fatty Acids in Bronchoalveolar Lavage in the Acute, Recovery and Convalescent Phases of SARS-CoV-2 Infection/ H. Wang, Bethesda, MD

ATS 2023 • Washington, DC